First Month of COVID-19 Vaccine Safety Monitoring — United States, December 14, 2020–January 13, 2021

Details

• Journal Article:
  Morbidity and Mortality Weekly Report
• Personal Author:
  Calvert, Geoffrey M. ; Clark, Thomas A. ; Gee, Julianne ; Jazwa, Amelia ; Licata, Charles ; Lindsey, Nicole ; Liu, Ruiling ; Markowitz, Lauri ; Marquez, Paige ; Martin, Stacey ; Myers, Tanya R. ; Nair, Narayan ; Shimabukuro, Tom T. ; Sotir, Mark J. ; Su, John R. ; Zhang, Bicheng
• Description:
  What is already known about this topic? Two COVID-19 vaccines have received Emergency Use Authorization for administration in the United States. In preauthorization clinical trials, local and systemic reactions were reported; no serious safety problems were detected. What is added by this report? Monitoring, conducted as part of the U.S. vaccination program, indicates reassuring safety profiles for COVID-19 vaccines. Local and systemic reactions were common; rare reports of anaphylaxis were received. No unusual or unexpected reporting patterns were detected. What are the implications for public health practice? Health care providers and vaccine recipients can be reassured about the safety of Pfizer BioNTech and Moderna COVID-19 vaccines. Counseling vaccine recipients to expect transient local and systemic reactions might ease concerns and encourage completion of the 2-dose vaccination series. [Description provided by NIOSH]
• Subjects:
  Adverse Drug Reaction Reporting Systems Communicable Diseases Coronavirus COVID-19 COVID-19 Vaccines Emergency Responders Health Care Facilities Workforce And Services Health Personnel Occupational Health Public Health Risk Assessment Safety Safety Management Vaccination Viral Diseases

  More +
• Keywords:
  Vaccines; Medical monitoring; Safety monitoring; Medical personnel; Health care; Health effects; Public health; Humans; Coronavirus; COVID-19; Disease prevention; Viral diseases; Infection control; Risk management; Recommendations; Effectiveness research; Emergency treatment; Clinical tests
• Source:
  MMWR 2021 Feb; 70(8):283-288
• Series:
  Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
• DOI:
  http://dx.doi.org/10.15585/mmwr.mm7008e3
• ISSN:
  0149-2195
• Pubmed ID:
  33630816
• Pubmed Central ID:
  PMC8344985
• Document Type:
  Text
• Genre:
  Journal Article
• Place as Subject:
  Georgia ; Maryland ; Ohio ; OSHA Region 3 ; OSHA Region 4 ; OSHA Region 5
• CIO:
  National Institute for Occupational Safety and Health (NIOSH)
• Topic:
  Workplace Safety & Health
• Location:
  North America
• Pages in Document:
  6 pdf pages
• Volume:
  70
• Issue:
  8
• NIOSHTIC Number:
  nn:20062090
• Contact Point Address:
  Julianne Gee, CDC COVID-19 Emergency Response Team, Atlanta, GA
• Email:
  jgee@cdc.gov
• Federal Fiscal Year:
  2021
• Peer Reviewed:
  False
• Collection(s):
  National Institute for Occupational Safety and Health Morbidity and Mortality Weekly Report (MMWR)
• Main Document Checksum:
  urn:sha-512:79943da63c3553204c4a8bf6e6ae4cbc8c6c8e3d815214db2370f4443e2d786771f5e61d2d599f8424b5aa242efa260ecd0056322399f00e74433e559e46962f
• Download URL:
  https://stacks.cdc.gov/view/cdc/109034/cdc_109034_DS1.pdf
• File Type:
  [PDF - 133.15 KB ]